Functional aspects of the somatostatinergic system in the retina and the potential therapeutic role of somatostatin in retinal disease

Histology and Histopathology

Volumn 20, Issue 2, 2005, Pages 615-632

  Casini, Giovanni ^a   Catalani, E ^a   Dal Monte, M ^b   Bagnoli, P ^b  

^a UNIVERSITY OF TUSCIA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Diabetic retinopathy; Retinal cells; Somatostatin receptors; Transgenic animals

Indexed keywords

ADENYLATE CYCLASE; BIM 23027; CYCLIC AMP; ION CHANNEL; NEUROTRANSMITTER; NITRIC OXIDE; OCTREOTIDE; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5;

ADJUVANT THERAPY; CELL STRUCTURE; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HORMONE ACTION; HUMAN; LASER COAGULATION; LASER SURGERY; NERVE CELL EXCITABILITY; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RETINA BIPOLAR GANGLION CELL; RETINA BLOOD VESSEL; RETINA CELL; RETINA DISEASE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

ADENYLATE CYCLASE; ANGIOGENESIS INHIBITORS; ANIMALS; CYCLIC AMP; DIABETIC RETINOPATHY; HUMANS; ION CHANNELS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PATHOLOGIC; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; RECEPTORS, SOMATOSTATIN; RETINA; RETINAL DISEASES; SIGNAL TRANSDUCTION; SOMATOSTATIN;

ANIMALIA; VERTEBRATA;

EID: 16344389226     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Ahern G.P., Klyachko V.A. and Jackson M.B. (2002). cGMP and S-nitrosylation: two routes for modulation of neuronal excitability by NO. Trends Neurosci, 25, 510-517.
2. Akopian A. (2000). Neuromodulation of ligand- and voltage-gated channels in the amphibian retina. Microsc. Res. Tech. 50, 403-410.
3. 2+) currents in rod and cone photoreceptors of the salamander retina. J. Neurosci. 20, 929-936.
4. Allen J.P., Hathway G.J., Clarke N.J., Jowett M.I., Topps S., Kendrick K.M., Humphrey P.P., Wilkinson L.S. and Emson P.C. (2003). Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur. J. Neurosci. 17, 1881-1895.
5. Ambati J., Chalam K.V., Chawla D.K., D'Angio C.T., Guillet E.G., Rose S.J., Vanderlinde R.E. and Ambati B.K. (1997). Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 115, 1161-1166.
6. Ayoub G.S. and Matthews G. (1992). Substance P modulates calcium current in retinal bipolar neurons. Vis. Neurosci. 8, 539-544.
7. Bagnoli P., Dal Monte M. and Casini G. (2003). Expression of neuropeptides and their receptors in the developing retina of mammals. Histol. Histopathol. 18, 1219-1242.
8. Baldysiak-Figiel A., Lang G.K., Kampmeier J. and Lang G.E. (2004). Octreotide prevents growth factor-induced proliferation of bovine retinal endothelial cells under hypoxia. J. Endocrinol. 180, 417-424.
9. Barber A.J. (2003). A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 283-290.
10. Bates D.O., Hillman N.J., Williams B., Neal C.R. and Pocock T.M. (2002). Regulation of microvascular permeability by vascular endothelial growth factors. J. Anat. 200, 581-597.
11. Bell G.I. and Polonsky K.S. (2001). Diabetes mellitus and genetically programmed defects in beta-cell function. Nature 414, 788-791.
12. Bigiani A., Petrucci C., Ghiaroni V., Dal Monte M., Cozzi A., Kreienkamp H.J., Richter D. and Bagnoli P. (2004). Functional correlates of somatostatin receptor 2 over-expression in the retina of mice with genetic deletion of somatostatin receptor 1. Brain Res. 1025, 177-185.
13. Blake A.D., Badway A.C. and Strowski M.Z. (2004). Delineating somatostatin's neuronal actions. Curr. Drug Targets CNS Neurol. Disord. 3, 153-160.
14. Boelen M.K., Boelen M.G. and Marshak D.W. (1998). Light-stimulated release of dopamine from the primate retina is blocked by 1-2-amino-4-phosphonobutyric acid (APB). Vis. Neurosci. 15, 97-103.
15. Brazeau P., Vale W., Burgus R., Ling N., Butcher M., Rivier J. and Guillemin R. (1973). Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77-79.
16. Brecha N.C. (2003). Peptide and peptide receptor expression and function in the vertebrate retina. In: The visual neurosciences. Chalupa L.M. and Werner J.S. (eds). The MIT Press. Cambridge (MA). pp 334-354.
17. Cai J. and Boulton M. (2002). The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye 16, 242-260.
18. Casini G., Rickman D.W., Sternini C. and Brecha N.C. (1997). Neurokinin 1 receptor expression in the rat retina. J. Comp. Neurol. 389, 496-507.
19. Casini G., Sabatini A., Catalani E., Willems D., Bosco L. and Brecha N.C. (2002). Expression of the neurokinin 1 receptor in the rabbit retina. Neuroscience 115, 1309-1321.
20. Casini G., Dal Monte M., Fornai F., Bosco L., Willems D., Yang Q., Zhou Z.J. and Bagnoli P. (2004a). Neurokinin 1 receptor expression and substance P physiological actions are developmentally regulated in the rabbit retina. Neuroscience 124, 147-160.
21. Casini G., Dal Monte M., Petrucci C., Gambellini G., Grouselle D., Allen J.P., Kreienkamp H.J., Richter D., Epelbaum J. and Bagnoli P. (2004b). Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2. Eur. J. Neurosci. 19, 43-54.
22. Catalani E., Gangitano C., Bosco L. and Casini G. (2004). Expression of the neurokinin 1 receptor in the mouse retina. Neuroscience 128, 519-530.
23. Celiker U. and Ilhan N. (2002). Nitric oxide and octreotide in retinal ischemia-reperfusion injury. Doc. Ophthalmol. 105, 327-338.
24. Colas B., Valencia A.M., Prieto J.C. and Arilla E. (1992). Somatostatin binding and modulation of adenylate cyclase in ovine retina membranes. Mol. Cell. Endocrinol. 88, 111-117.
25. Cristiani R., Fontanesi G., Casini G., Petrucci C., Viollet C. and Bagnoli P. (2000). Expression of somatostatin subtype 1 receptor in the rabbit retina. Invest. Ophthalmol. Vis. Sci. 41, 3191-3199.
26. Cristiani R., Petrucci C., Dal Monte M. and Bagnoli P. (2002). Somatostatin (SRIF) and SRIF receptors in the mouse retina. Brain Res. 936, 1-14.
27. Csaba Z. and Dournaud P. (2001). Cellular biology of somatostatin receptors. Neuropeptides 35, 1-23.
28. Cudeiro J. and Rivadulla C. (1999). Sight and insight - on the physiological role of nitric oxide in the visual system. Trends Neurosci. 22, 109-116.
29. Cunningham J.R. and Neal M.J. (1983). Effect of gamma-aminobutyric acid agonists, glycine, taurine and neuropeptides on acetylcholine release from the rabbit retina. J. Physiol. 336, 563-577.
30. Dal Monte M., Petrucci C., Cozzi A., Allen J.P. and Bagnoli P. (2003a). Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina. Naunyn Schmiedebergs Arch. Pharmacol. 367, 188-192.
31. Dal Monte M., Petrucci C., Vasilaki A., Cervia D., Grouselle D., Epelbaum J., Kreienkamp H.J., Richter D., Hoyer D. and Bagnoli P. (2003b). Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina. Neuropharmacology 45, 1080-1092.
32. Danesi R., Agen C., Benelli U., Paolo A.D., Nardini D., Bocci G., Basolo F., Campagni A. and Tacca M.D. (1997). Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS201-995). Clin. Cancer Res. 3, 265-272.
33. Davis M.I., Wilson S.H. and Grant M.B. (2001). The therapeutic problem of proliferative diabetic retinopathy: targeting somatostatin receptors. Horm. Metab. Res. 33, 295-299.
34. DeBosch B.J., Baur E., Deo B.K., Hiraoka M. and Kumagai A.K. (2001). Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. J. Neurochem. 77, 1157-1167.
35. Djamgoz M.B. and Wagner H.J. (1992). Localization and function of dopamine in the adult vertebrate retina. Neurochem. Int. 20, 139-191.
36. Engelmann R. and Peichl L. (1996). Unique distribution of somatostatin-immunoreactive cells in the retina of the tree shrew (Tupaia belangeri). Eur. J. Neurosci. 8, 220-228.
37. Feigenspan A. and Bormann J. (1994). Facilitation of GABAergic signaling in the retina by receptors stimulating adenylate cyclase. Proc. Natl. Acad. Sci. USA 91, 10893-10897.
38. Firth S.I., Boelen M.K. and Morgan I.G. (1998). Enkephalin, neurotensin and somatostatin increase cAMP levels in the chicken retina. Aust. N. Z. J. Ophthalmol. 26, S65-S67.
39. Florio T. and Schettini G. (1996). Multiple intracellular effectors modulate physiological functions of the cloned somatostatin receptors. J. Mol. Endocrinol. 17, 89-100.
40. Fontanesi G., Casini G., Thanos S. and Bagnoli P. (1997). Transient somatostatin-immunoreactive ganglion cells in the developing rat retina. Brain Res. Dev. Brain Res. 103, 119-125.
41. Fontanesi G., Gargini C. and Bagnoli P. (2000). Postnatal development of somatostatin 2A (sst2A) receptors expression in the rabbit retina. Brain Res. Dev. Brain Res. 123, 67-80.
42. Forloni G., Lucca E., Angeretti N., Chiesa R. and Vezzani A. (1997). Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J. Neurochem. 68, 319-327.
43. Funatsu H. and Yamashita H. (2003). Pathogenesis of diabetic retinopathy and the renin-angiotensin system. Ophthalmic Physiol. Opt. 23, 495-501.
44. Garcia de la Torre N., Wass J.A. and Turner H.E. (2002). Antiangiogenic effects of somatostatin analogues. Clin. Endocrinol. 57, 425-441.
45. Gargiulo P., Giusti C., Pietrobono D., La Torre D., Diacono D. and Tamburrano G. (2004). Diabetes mellitus and retinopathy. Dig. Liver Dis. 36, S101-S105.
46. Gerich J.E. (2003). Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin. Proc. 78, 447-456.
47. Grant M.B. and Caballero S. (2002). Somatostatin analogues as drug therapies for retinopathies. Drugs Today 38, 783-791.
48. Hannon J.P., Nunn C., Stolz B., Bruns C., Weckbecker G., Lewis I., Troxler T., Hurth K. and Hoyer D. (2002a). Drug design at peptide receptors: somatostatin receptor ligands. J. Mol. Neurosci. 18, 15-27.
49. 1-5 receptor mRNA and binding in mouse brain by semi-quantitative RT-PCR, in situ hybridisation histochemistry and receptor autoradiography. Neuropharmacology 42, 396-413.
50. Helboe L. and Moller M. (1999). Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest. Ophthalmol. Vis. Sci. 40, 2376-2382.
51. Ishikawa A., Ishiguro S. and Tamai M. (1996). Accumulation of gamma-aminobutyric acid in diabetic rat retinal Muller cells evidenced by electron microscopic immunocytochemistry. Curr. Eye Res. 15, 958-964.
52. Ishimoto I., Millar T., Chubb I.W. and Morgan I.G. (1986). Somatostatin-immunoreactive amacrine cells of chicken retina: retinal mosaic, ultrastructural features, and light-driven variations in peptide metabolism. Neuroscience 17, 1217-1233.
53. Jaffrey S.R. and Snyder S.H. (1995). Nitric oxide: a neural messenger. Annu. Rev. Cell. Dev. Biol. 11, 417-440.
54. Johnson J., Caravelli M.L. and Brecha N.C. (2001). Somatostatin inhibits calcium influx into rat rod bipolar cell axonal terminals. Vis. Neurosci. 18, 101-108.
55. Johnson J., Wu V., Wong H., Walsh J.H. and Brecha N.C. (1999). Somatostatin receptor subtype 2A expression in the rat retina. Neuroscience 94, 675-683.
56. Johnson J., Wong H., Walsh J.H. and Brecha N.C. (1998). Expression of the somatostatin subtype 2A receptor in the rabbit retina. J. Comp. Neurol. 393, 93-101.
57. Kelly M.A., Rayner M.L., Mijovic C.H. and Barnett A.H. (2003). Molecular aspects of type 1 diabetes. Mol. Pathol. 56, 1-10.
58. Khan Z.A. and Chakrabarti S. (2003). Growth factors in proliferative diabetic retinopathy. Exp. Diabesity Res. 4, 287-301.
59. Kirkegaard C., Norgaard K., Snorgaard O., Bek T., Larsen M. and Lund-Andersen H. (1990). Effect of one year continuous subcutaneous infusion of a somatostatin analogue, octreotide, on early retinopathy, metabolic control and thyroid function in Type I (insulin-dependent) diabetes mellitus. Acta Endocrinol. 122, 766-772.
60. Klisovic D.D., O'Dorisio M.S., Katz S.E., Sall J.W., Balster D., O'Dorisio T.M., Craig E. and Lubow M. (2001). Somatostatin receptor gene expression in human ocular tissues: RT-PCR and immunohistochemical study. Invest. Ophthalmol. Vis. Sci. 42, 2193-2201.
61. Kopchick J.J. and Okada S. (2001). Growth hormone receptor antagonists: discovery and potential uses. Growth Horm. IGF Res. 11, S103-S109.
62. Kraus M.M. and Prast H. (2002). Involvement of nitric oxide, cyclic GMP and phosphodiesterase 5 in excitatory amino acid and GABA release in the nucleus accumbens evoked by activation of the hippocampal fimbria. Neuroscience 112, 331-343.
63. Kreienkamp H.J., Akgun E., Baumeister H., Meyerhof W. and Richter D. (1999). Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs. FEBS Lett. 462, 464-466.
64. Kuang H., Zou W., Liu D., Shi R., Cheng L., Yin H. and Liu X. (2003). The potential role of IGF-I receptor mRNA in rats with diabetic retinopathy. Chin. Med. J. 116, 478-480.
65. Lahlou H., Guillermet J., Hortala M., Vernejoul F., Pyronnet S., Bousquet C. and Susini C. (2004). Molecular signaling of somatostatin receptors. Ann. NY Acad. Sci. 1014, 121-131.
66. Larsen J.N., Bersani M., Olcese J., Holst J.J. and Moller M. (1990). Somatostatin and prosomatostatin in the retina of the rat: an immunohistochemical, in-situ hybridization, and chromatographic study. Vis. Neurosci. 5, 441-452.
67. Lawnicka H., Stepien H., Wyczolkowska J., Kolago B., Kunert-Radek J. and Komorowski J. (2000). Effect of somatostatin and octreotide on proliferation and vascular endothelial growth factor secretion from murine endothelial cell line (HECa10) culture. Biochem. Biophys. Res. Commun. 268, 567-571.
68. Li Q., Zemel E., Miller B. and Perlman I. (2003). NADPH diaphorase activity in the rat retina during the early stages of experimental diabetes. Graefes Arch. Clin. Exp. Ophthalmol 241, 747-756.
69. Liepe B.A., Stone C., Koistinaho J., Copenhagen D.R. (1994). Nitric oxide synthase in Muller cells and neurons of salamander and fish retina. J. Neurosci. 14, 7641-7654.
70. 2 somatostatin receptor growth inhibitory signaling. FASEB J. 15, 2300-2302.
71. Low M.J., Otero-Corchon V., Parlow A.F., Ramirez J.L., Kumar U., Patel Y.C. and Rubinstein M. (2001). Somatostatin is required for masculinization of growth hormone-regulated hepatic gene expression but not of somatic growth. J. Clin. Invest. 107, 1571-1580.
72. Mallet B., Vialettes B., Haroche S., Escoffier P., Gastaut P., Taubert J.P. and Vague P. (1992). Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995. Diabete Metab. 18, 438-444.
73. Margulis A., Pozdnyakov N., Dang L. and Sitaramayya A. (1998). Soluble guanylate cyclase and nitric oxide synthase in synaptosomal fractions of bovine retina. Vis. Neurosci. 15, 867-873.
74. Marshak D.W. (1989). Peptidergic neurons of the macaque monkey retina. Neurosci. Res. 10, S117-S130.
75. 1) modulates the release of somatostatin in rat retina. Neurosci. Lett. 356, 13-16.
76. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G. and Hanoune J. (1992). Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12, 3350-3360.
77. McCombe M., Lightman S., Eckland D.J., Hamilton A.M. and Lightman S.L. (1991). Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study. Eye 5, 569-575.
78. Mitrofanis J., Robinson S.R. and Provis J.M. (1989). Somatostatinergic neurones of the developing human and cat retinae. Neurosci. Left. 104, 209-216.
79. Morgans C.W. (2000). Neurotransmitter release at ribbon synapses in the retina. Immunol. Cell Biol. 78, 442-446.
80. Mori M., Aihara M. and Shimizu T. (1997). Differential expression of somatostatin receptors in the rat eye: SSTR4 is intensely expressed in the iris/ciliary body. Neurosci. Lett. 223, 185-188.
81. Neal M., Cunningham J. and Matthews K. (1998). Selective release of nitric oxide from retinal amacrine and bipolar cells. Invest. Ophthalmol. Vis. Sci. 39, 850-853.
82. Nishimura C. and Kuriyama K. (1985). Alterations in the retinal dopaminergic neuronal system in rats with streptozotocin-induced diabetes. J. Neurochem. 45, 448-455.
83. Olias G., Viollet C., Kusserow H., Epelbaum J. and Meyerhof W. (2004). Regulation and function of somatostatin receptors. J. Neurochem. 89, 1057-1091.
84. Patel Y.C. (1999). Somatostatin and its receptor family. Front. Neuroendocrinol. 20, 157-198.
85. Pavan B., Fiorini S., Dal Monte M., Lunghi L., Biondi C., Bagnoli P. and Cervia D. (2004). Somatostatin coupling to adenylyl cyclase activity in the mouse retina. Naunyn Schmiedebergs Arch. Pharmacol. 370, 91-98.
86. Pawlikowski M. and Melen-Mucha G. (2003). Perspectives of new potential therapeutic applications of somatostatin analogs. Neuro Endocrinol. Lett. 24, 21-27.
87. Petrucci C., Resta V., Fieni F., Bigiani A. and Bagnoli P. (2001). Modulation of potassium current and calcium influx by somatostatin in rod bipolar cells isolated from the rabbit retina via sst2 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 363, 680-694.
88. Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H.J., Hollt V. and Schulz S. (2001). Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem. 276, 14027-14036.
89. Pineda J., Kogan J.H. and Aghajanian G.K. (1996). Nitric oxide and carbon monoxide activate locus coeruleus neurons through a cGMP-dependent protein kinase: involvement of a nonselective cationic channel. J. Neurosci. 16, 1389-1399.
90. Pradayrol L., Jornvall H., Mutt V. and Ribet A. (1980). N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 109, 55-58.
91. Reisine T. and Bell G.I. (1995). Molecular properties of somatostatin receptors. Neuroscience 67, 777-790.
92. Rickman D.W., Blanks J.C. and Brecha N.C. (1996). Somatostatin-immunoreactive neurons in the adult rabbit retina. J. Comp. Neurol. 365, 491-503.
93. Robinson C.J. and Stringer S.E. (2001). The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell. Sci. 114, 853-865.
94. Rocheville M., Lange D.C., Kumar U., Sasi R., Patel R.C. and Patel Y.C. (2000). Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275, 7862-7869.
95. Sagar S.M. (1987). Somatostatin-like immunoreactive material in the rabbit retina: immunohistochemical staining using monoclonal antibodies. J. Comp. Neurol. 266, 291-299.
96. Sagar S.M. and Marshall P.E. (1988). Somatostatin-like immunoreactive material in associational ganglion cells of human retina. Neuroscience 27, 507-516.
97. Sagar S.M., Marshall P.E. and Landis D.M. (1985). Immunoreactive somatostatin in the rat retina: light microscopic immunocyto-chemistry and chromatographic: characterization. Brain Res. 336, 235-242.
98. Saltiel A.R. and Kahn C.R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
99. Sanchez-Chavez G. and Salceda R. (2001). Acetyl- and butyrylcholinesterase molecular forms in normal and streptozotocin-diabetic rat retinal pigment epithelium. Neurochem. Int. 39, 209-215.
100. Schorderet M., Sovilla J.Y. and Magistretti P.J. (1981). VIP-and glucagon-induced formation of cyclic AMP in intact retinae in vitro. Eur. J. Pharmacol. 71, 131-133.
101. 125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors. Eur. J. Pharmacol. 348, 311-320.
102. Simo R., Lecube A., Segura R.M., Garcia Arumi J. and Hernandez C. (2002). Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 134, 376-382.
103. Sitaramayya A. (2002). Soluble guanylate cyclases in the retina. Mol. Cell. Biochem. 230, 177-186.
104. Smith S.B. (2002). Diabetic Retinopathy and the NMDA Receptor. Drug News Perspect. 15, 226-232.
105. Southam E. and Garthwaite J. (1993). The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32, 1267-1277.
106. Spira A.W., Shimizu Y. and Rorstad O.P. (1984). Localization, chromatographic characterization, and development of somatostatin-like immunoreactivity in the guinea pig retina. J. Neurosci. 4, 3069-3079.
107. Spranger J. and Pfeiffer A.F. (2001). New concepts in pathogenesis and treatment of diabetic retinopathy. Exp. Clin. Endocrinol. Diabetes 109, S438-S450.
108. Spranger J., Mohlig M., Osterhoff M., Buhnen J., Blum W.F. and Pfeiffer A.F. (2001). Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy-evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm. Metab. Res. 33, 312-316.
109. Stamler J.S., Toone E.J., Lipton S.A. and Sucher N.J. (1997). (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691-696.
110. Tannenbaum G.S. and Epelbaum J. (2000). Somatostatin. In: Handbook of Physiology - Section 7: The endocrine system. Vol.V: Hormonal control of growth. Goodman H.M. and Kostyo J.L. (eds). Oxford University Press. New York. pp 221-265.
111. ten Bokum A.M., Melief M.J., Schonbrunn A., van der Ham F., Lindeman J., Hofland L.J., Lamberts S.W. and van Hagen P.M. (1999). Immunohistochemical localization of somatostatin receptor sst2A in human rheumatoid synovium. J. Rheumatol. 26, 532-535.
112. Thermos K. (2003). Functional mapping of somatostatin receptors in the retina: a review. Vision Res. 43, 1805-1815.
113. Tornqvist K. and Ehinger B. (1988). Peptide immunoreactive neurons in the human retina. Invest. Ophthalmol. Vis. Sci. 29, 680-686.
114. Tornqvist K., Uddman R., Sundler F. and Ehinger B. (1982). Somatostatin and VIP neurons in the retina of different species. Histochemistry 76, 137-152.
115. Troger J., Neyer S., Heufler C., Huemer H., Schmid E., Griesser U., Kralinger M., Kremser B., Baldissera I. and Kieselbach G. (2001). Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina. Invest. Ophthalmol. Vis. Sci. 42, 1045-1050.
116. van Hagen P.M., Baarsma G.S., Mooy C.M., Ercoskan E.M., ter Averst E., Hofland L.J., Lamberts S.W. and Kuijpers RW. (2000). Somatostatin and somatostatin receptors in retinal diseases. Eur. J. Endocrinol. 143, S43-S51.
117. Vasilaki A., Gardette R., Epelbaum J. and Thermos K. (2001). NADPH-diaphorase colocalization with somatostatin receptor subtypes sst2A and sst2B in the retina. Invest. Ophthalmol. Vis. Sci. 42, 1600-1609.
118. Vasilaki A., Mouratidou M., Schulz S. and Thermos K. (2002). Somatostatin mediates nitric oxide production by activating sst(2) receptors in the rat retina. Neuropharmacology 43, 899-909.
119. 2) are coupled to Go and modulate GTPase activity in the rabbit retina. J. Neurochem. 84, 625-632.
120. Vasilaki A., Papadaki T., Notas G., Kolios G., Mastrodimou N., Hoyer D., Tsilimbaris M., Kouroumalis E., Pallikaris I. and Thermos K. (2004). Effect of somatostatin on nitric oxide production in human retinal pigment epithelium cell cultures. Invest. Ophthalmol. Vis. Sci. 45, 1499-1506.
121. Völgyi B. and Bloomfield S.A. (2002). Axonal neurofilament-H immunolabeling in the rabbit retina. J. Comp. Neurol. 453, 269-279.
122. Völgyi B., Xin D., Amarillo Y. and Bloomfield S.A. (2001). Morphology and physiology of the polyaxonal amacrine cells in the rabbit retina. J. Comp. Neurol. 440, 109-125.
123. Watling K.J. and Dowling J.E. (1983). Effects of vasoactive intestinal peptide and other peptides on cyclic AMP accumulation in intact pieces and isolated horizontal cells of the teleost retina. J Neurochem. 41, 1205-1213.
124. Weckbecker G., Lewis I., Albert R., Schmid H.A., Hoyer D. and Bruns C. (2003). Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat. Rev. Drug Discov. 2, 999-1017.
125. Weill C.L. (1991). Somatostatin (SRIF) prevents natural motoneuron cell death in embryonic chick spinal cord. Dev. Neurosci. 13, 377-381.
126. White C.A. and Chalupa L.M. (1991). Subgroup of alpha ganglion cells in the adult cat retina is immunoreactive for somatostatin. J. Comp. Neurol. 304, 1-13.
127. White C.A., Chalupa L.M., Johnson D. and Brecha N.C. (1990). Somatostatin-immunoreactive cells in the adult cat retina. J. Comp. Neurol. 293, 134-150.
128. Wilkinson-Berka J.L., Kelly D.J. and Gilbert R.E. (2001). The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes. J. Vasc. Res. 38, 527-535.
129. Witmer A.N., Blaauwgeers H.G., Weich H.A., Alitalo K., Vrensen G.F. and Schlingemann R.O. (2002). Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest. Ophthalmol. Vis. Sci. 43, 849-857.
130. Witmer A.N., Vrensen G.F., Van Noorden C.J. and Schlingemann R.O. (2003). Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res. 22, 1-29.
131. Wood J. and Garthwaite J. (1994). Models of the diffusional spread of nitric oxide: implications for neural nitric oxide signalling and its pharmacological properties. Neuropharmacology 33, 1235-1244.
132. Xiang Z., Jiang L. and Kang Z. (2001). Transient expression of somatostatin mRNA in developing ganglion cell layers of rat retina. Brain Res. Dev. Brain Res. 128, 25-33.
133. Yang D.S., Boelen M.K. and Morgan I.G. (1997). Development of the enkephalin-, neurotensin- and somatostatin-like (ENSLI) amacrine cells in the chicken retina. Brain Res. Dev. Brain Res. 101, 57-65.
134. Zagotta W.N. and Siegelbaum S.A. (1996). Structure and function of cyclic nucleotide-gated channels. Annu. Rev. Neurosci. 19, 235-263.
135. Zalutsky R.A and Miller R.F. (1990). The physiology of somatostatin in the rabbit retina. J. Neurosci. 10, 383-393.
136. Zheng H., Bailey A., Jiang M.H., Honda K., Chen H.Y., Trumbauer M.E., Van der Ploeg L.H., Schaeffer J.M., Leng G. and Smith R.G. (1997). Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. Mol. Endocrinol. 11, 1709-1717.